Charles Brandes acquired 2.3M MerckInc shares worth $262M. That's 1.81% of their equity portfolio (9th largest holding). The first MerckInc trade was made in Q1 2013. Since then Charles Brandes bought shares 21 more times and sold shares on 31 occasions. The stake costed the investor $148M, netting the investor a gain of 77% so far.